{
    "2021-11-26": [
        [
            {
                "time": "2023-11-25",
                "original_text": "恒瑞医药多项药物获临试批准通知",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "药物",
                        "临床试验",
                        "批准"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-11-25",
                "original_text": "北向资金净卖出近45亿结束连续5日净买入，招商银行净卖出超6亿元",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净卖出",
                        "招商银行"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-11-25",
                "original_text": "恒瑞医药：卡瑞利珠单抗联合苹果酸法米替尼和注射用紫杉醇治疗晚期实体瘤的开放、多中心的Ib/II期临床研究获批临床试验",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "卡瑞利珠单抗",
                        "临床试验",
                        "批准"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-11-25",
                "original_text": "恒瑞医药子公司获得“SHR-1701注射液”药物临床试验批准",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "SHR-1701注射液",
                        "临床试验",
                        "批准"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-11-25",
                "original_text": "恒瑞医药：注射用卡瑞利珠单抗、苹果酸法米替尼胶囊临床试验获批",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "卡瑞利珠单抗",
                        "法米替尼",
                        "临床试验",
                        "批准"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-11-25",
                "original_text": "恒瑞医药：多项药物获批开展临床试验",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "药物",
                        "临床试验",
                        "批准"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-11-25",
                "original_text": "三次搭“快车”，基石药业商业化提速，管线2.0持续扩容",
                "features": {
                    "keywords": [
                        "基石药业",
                        "商业化",
                        "管线2.0",
                        "扩容"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-11-25",
                "original_text": "医疗健康：板块具备配置价值 关注创新国际化路线",
                "features": {
                    "keywords": [
                        "医疗健康",
                        "配置价值",
                        "创新国际化"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-11-25",
                "original_text": "A股融资融券日报：两融余额增加16.32亿元（11月25日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额",
                        "增加"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-11-25",
                "original_text": "多个重磅疫苗品种将陆续上市",
                "features": {
                    "keywords": [
                        "疫苗",
                        "重磅",
                        "上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}